Product Overview: Raloxos Driada Medical
Raloxifene hydrochloride is a selective estrogen receptor modulator (SERM) extensively studied for its tissue-specific estrogenic and anti-estrogenic properties. This benzothiophene derivative demonstrates unique receptor binding characteristics that make it valuable for investigating estrogen pathway modulation in various tissue types. Researchers at Stroid UK Shop utilise raloxifene to examine how selective estrogen receptor antagonism affects cellular signalling cascades in laboratory models. The compound exhibits differential activity profiles across target tissues, functioning as an estrogen antagonist in reproductive tissues while maintaining agonist properties in bone and cardiovascular systems.
Laboratory Applications
Scientific investigations focus on raloxifene’s ability to modulate estrogen receptor alpha and beta subtypes with tissue selectivity. Research applications include studying bone mineral density preservation mechanisms, examining cardiovascular protective pathways, and analysing breast tissue estrogen receptor antagonism in cell culture models. The compound serves as a reference standard for comparing other raloxifene research chemicals and investigating SERM pharmacology. Studies evaluate its effects on osteoblast proliferation, lipid metabolism modulation, and endothelial function in controlled laboratory environments. Researchers also examine its potential interactions with other compounds commonly used alongside selective androgen receptor modulators and research peptides to understand comprehensive hormonal pathway interactions.
Technical Specifications
| CAS Registry | 82640-04-8 (HCl salt) |
|---|---|
| Molecular Formula | C₂₈H₂₇NO₄S·HCl |
| Molecular Weight | 510.05 g/mol |
| Chemical Class | Benzothiophene SERM |
| Solubility | DMSO, ethanol, limited aqueous |
| Storage | Room temperature, dry conditions |
Research Compliance
This raloxifene hydrochloride preparation is manufactured by Driada Medical exclusively for in-vitro research applications. The compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper handling protocols, appropriate storage conditions, and compliance with institutional guidelines when conducting studies with this selective estrogen receptor modulator.
